MARIPOSA: Combination therapy as the new standard of care for EGFR-mutated NSCLC - Medizinonline

… Dieser Inhalt ist nur für Benutzer der Gruppe: Medizinische Fachperson zugänglich Jetzt beitreten Already a member? Log in here...

Dieser Inhalt ist nur für Benutzer der Gruppe: Medizinische Fachperson zugänglich
Jetzt beitreten

Already a member? Log in here

Autoren

Birke Dikken

Publikation

InFo ONKOLOGIE & HÄMATOLOGIE

Related Topics

Previous Article

Atopic dermatitis and allergies Atopic dermatitis and allergies

Type 2 inflammation and other factors

Pulmonary hypertension

PH and lung diseases

You May Also Like

7 min

Rare pulmonary syndromes

Yellow nail and Swyer-James syndrome

7 min

Vaccinations against viral respiratory infections

Influenza, Covid-19 and RSV – Update 2025

4 min

GLP1-RA therapy

Improvement in either weight or HbA1c – but never both

6 min

Suicide

Dealing with trauma after suicide loss: What do bereaved people experience as effective?

4 min

COPD exacerbations

Fast therapy initiation is not much better than expected

- Education
- Pneumology
- RX
- Studies

8 min

Lung cancer with EGFR mutation

New perspectives in first-line therapy

- Congress Reports
- Oncology
- Pneumology
- RX
- Studies

10 min

Collagenoses

Scleroderma – Current recommendations for diagnosis and therapy 2025

6 min

Galenic systems

Advantages of topical pharmacotherapy – Update 2025

Input your search keywords and press Enter.